Answers are grounded in this paper and cite their sources.
Prostate cancer risk assessment has become increasingly complex, with a long and growing menu of risk assessment tools available. Instrument selection for clinical practice and research must balance accuracy, validation, and applicability.
No takes yet. Share an insight, caveat, or question.
Matthew R. Cooperberg (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: